CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Dr. Sean McCarthy, PhD, will speak at the Duke Beijing Healthcare Forum.
News | 05. 26. 2007
